Currently, there are 49.08M common shares owned by the public and among those 37.78M shares have been available to trade.
The company’s stock has a 5-day price change of -5.97% and -37.44% over the past three months. BASE shares are trading -25.13% year to date (YTD), with the 12-month market performance up to 9.20% higher. It has a 12-month low price of $13.97 and touched a high of $32.00 over the same period. BASE has an average intraday trading volume of 515.93K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -23.83%, -29.50%, and -24.14% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Couchbase Inc (NASDAQ: BASE) shares accounts for 72.67% of the company’s 49.08M shares outstanding.
It has a market capitalization of $848.23M and a beta (3y monthly) value of 0.59. The earnings-per-share (ttm) stands at -$1.65. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.41% over the week and 5.01% over the month.
Earnings per share for the fiscal year are expected to increase by 33.83%, and 52.79% over the next financial year.
Looking at the support for the BASE, a number of firms have released research notes about the stock. Goldman stated their Sell rating for the stock in a research note on June 06, 2024, with the firm’s price target at $18. UBS coverage for the Couchbase Inc (BASE) stock in a research note released on May 22, 2024 offered a Neutral rating with a price target of $31. Barclays was of a view on February 20, 2024 that the stock is Equal Weight, while Wells Fargo gave the stock Overweight rating on January 08, 2024, issuing a price target of $26. Oppenheimer on their part issued Outperform rating on December 14, 2023.
